Table 3 Comparison between the 3 groups as regards post-operative data using Kruskal–Wallis and Chi square tests and significant KW test was followed by post hoc multiple comparisons using Bonferroni test to detect the significant pairs
Variable | CPA group (20) | Finasteride group (20) | Control group (20) | Kruskal–Wallis test |
|---|---|---|---|---|
Median (IQR) | Median (IQR) | Median (IQR) | P value | |
Hb (g/dL) | 12.5 (11.9 – 13)†‡ | 12 (11.3 – 12.7)† | 11.5 (11.1 – 12) | = 0.0073** |
HCT (%) | 40.7 (39 – 42)†‡ | 38.2 (36.6 – 39.5)† | 37 (36 – 38) | < 0.0001** |
PSA (ng/dL) | 0.85 (0.64 – 1.09)†‡ | 1.05 (0.89 – 1.3) | 1.24 (0.9 – 1.5) | = 0.0015** |
Histopathology (MVD) (vessel/HPF) | 8 (7 – 9.5)†‡ | 14 (12.5 – 15.5)† | 20 (18.5 – 21.5) | < 0.0001** |
Variable | CPA group (20) | Finasteride group (20) | Control group (20) | Chi square test | ||
|---|---|---|---|---|---|---|
P value | ||||||
Postoperative haematuria | + ve | 0/20 (0.0%) | 0/20 (0.0%) | 3/20 (15%) | = 0.042* | |